首页> 外文OA文献 >Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

【2h】

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

机译：非糖尿病个体中的代谢和临床结果，分配给Chlorthalthalone，氨氯堇，或丽思诺普利作为高血压的初始治疗：抗高血压和脂质降低治疗的报告，以防止心脏病发作试验（ALLHAT）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
H. R. Black; B. Davis; J. Barzilay; C. Nwachuku; C. Baimbridge; H. Marginean; J. T. Wright; J. Basile; N. D. Wong; P. Whelton; R. A. Dart; U. Thadani;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Pre [J] . Black HR, Davis B, Barzilay J, Diabetes care . 2008,第2期

机译：代谢综合征被分配为氯噻酮，氨氯地平或赖诺普利作为高血压的初始治疗的非糖尿病个体的代谢和临床结局：从降压降脂治疗到高血压的报告
2. Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J] . Paul A. Heidenreich MD MS, Barry R. Davis MD PhD, Jeffrey A. Cutler MD MPH, Journal of General Internal Medicine . 2008,第5期

机译：氯噻酮，氨氯地平和赖诺普利作为高血压患者的第一步治疗的成本效益：降压降脂治疗预防心脏病发作试验的分析（ALLHAT）
3. Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [J] . Heidenreich PA, Davis BR, Cutler JA, Journal of general internal medicine . 2008,第5期

机译：氯噻酮，氨氯地平和赖诺普利作为高血压患者的第一步治疗的成本效益：预防心脏病发作的降压降脂治疗的分析（ALLHAT）。
4. Relationship between Metabolic Syndrome and Its Diagnosis and Treatment of Hypertension Strategy [C] . Pan Xingshou, Huang Zhaohe, Lan Jingsheng ICAMCS 2011;International conference on advanced materials and computer science . 2012

机译：代谢综合征与高血压策略的诊治关系
5. Disparities in Socioeconomic Context and Response to Antihypertensive Medication in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [D] . Shahu, Andi. 2018

机译：社会经济背景中的差异以及在预防高血压和降脂治疗中预防心脏病发作试验中对降压药物的反应（ALLHAT）
6. Cost-effectiveness of Chlorthalidone Amlodipine and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [O] . Paul A. Heidenreich, Barry R. Davis, Jeffrey A. Cutler, 2008

机译：氯噻酮氨氯地平和赖诺普利作为高血压患者的第一步治疗的成本效益：降压降脂治疗预防心脏病发作试验的分析（ALLHAT）
7. Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [O] . Heidenreich, Paul A., Davis, Barry R., Cutler, Jeffrey A., 2008

机译：氯噻酮，氨氯地平和赖诺普利作为高血压患者的第一步治疗的成本效益：降压降脂治疗预防心脏病发作试验的分析（ALLHAT）

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

著录项

相似文献

相关主题

期刊订阅